Nasdaq Surf

Is a clinical-stage immuno-oncology company which focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies.

Nasdaq surf. PennyStock101 Feb 25 2020. NASDAQSURF traded at 1255 at close of the session on Monday Feb 08 made an upward move of 1235 on its previous days price. The companys product pipeline includes CD47 CD73 SRF231 SRF373 SRF617 SRF388.

019 204 DATA AS OF Feb 19 2021. NASDAQSURF announced its earnings results on Tuesday November 10th. It develops therapies for the treatment of cancer.

The jump to weekly highs of 1269 on Monday Feb 08 added 1143 to the stocks daily price. The company reported 039 EPS for the quarter missing the Thomson Reuters consensus estimate of 038 by 001. Most recently the companys share price was 909 and it changed around 001 or 0 from the last close which brings the market valuation of the company to 36507.

NASDAQSURFs traded shares were 1029811 with the beta value of the company hitting 0. Looking at the stock we see that its previous. NASDAQSURF trade information After registering a -5 downside in the last session Surface Oncology Inc.

24 2021 GLOBE NEWSWIRE -- Surface Oncology Nasdaq. During the last session Surface Oncology Inc. View real-time stock prices and stock quotes for a full financial overview.

Common Stock SURF Surface Oncology Inc. NASDAQSURF historical trading data shows that trading volumes averaged 9734 Million over the past 10 days and 139 Million over the past 3 months. EST View Interactive SURF Charts.